Fellowship · Rochester, MN
Sponsored by Mayo Clinic College of Medicine and Science
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab.
Cancer discovery · 2021 · 515 citations · Jennifer Sauter
Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer.
Nature cancer · 2022 · 298 citations · Jennifer Sauter
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
Cancer cell · 2024 · 183 citations · Jennifer Sauter
Treatment of Pleural Mesothelioma: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 56 citations · Jennifer Sauter
Pathophysiological insights into HFpEF from studies of human cardiac tissue.
Nature reviews. Cardiology · 2025 · 53 citations · Melanie Bois
The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022 · 169 citations · Jennifer Sauter
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Blood · 2022 · 134 citations · Amy Swanson
Chromothripsis-Mediated Small Cell Lung Carcinoma.
Cancer discovery · 2025 · 45 citations · Jennifer Sauter